Contact
Please use this form to send email to PR contact of this press release:
ROSEN, RECOGNIZED INVESTOR COUNSEL, Reminds BioMarin Pharmaceutical Inc. Investors of Important November 24 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – BMRN
TO: